Client & Alumni News

Saladax Biomedical Welcomes New Guidelines for Chemotherapy

Saladax Biomedical Inc., an anchor tenant in Ben Franklin TechVentures, announced that it welcomes new guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology that “strongly recommend” monitoring levels of 5-Fluorouracil (5-FU) in patients receiving chemotherapy. Saladax develops novel blood tests that increase the impact of personalized medicine by bringing chemotherapeutic drug monitoring to oncologists and adherence testing to psychiatrists. More: